Basic characteristics of study cohort | Quartile of Spd + Spm concentration | P for effectb | P for trendc | |||
---|---|---|---|---|---|---|
Q1 (n = 155) | Q2 (n = 156) | Q3 (n = 156) | Q4 (n = 155) | |||
Fasting plasma glucose (mmol/l) | ||||||
Model 1d | 5.67 | 5.56 | 5.89 | 5.94 | 0.019 | 0.010 |
Model 2e | 5.96 | 5.84 | 6.18 | 6.25 | 0.013 | 0.007 |
Fasting plasma insulin (μU/ml) | ||||||
Model 1 | 5.60 | 5.95 | 5.98 | 6.21 | 0.685 | 0.246 |
Model 2 | 5.88 | 6.11 | 6.15 | 6.40 | 0.784 | 0.320 |
HOMA–IR | ||||||
Model 1 | 1.41 | 1.47 | 1.60 | 1.62 | 0.282 | 0.057 |
Model 2 | 1.52 | 1.55 | 1.68 | 1.72 | 0.329 | 0.073 |
Fructosamine (μmol/l) | ||||||
Model 1 | 251 | 256 | 256 | 260 | 0.213 | 0.045 |
Model 2 | 261 | 264 | 264 | 268 | 0.315 | 0.081 |
Quartile of Spm concentration | P for effectb | P for trendc | ||||
---|---|---|---|---|---|---|
Q1 (n = 155) | Q2 (n = 156) | Q3 (n = 156) | Q4 (n = 155) | |||
Fasting plasma glucose (mmol/l) | ||||||
Model 1d | 5.64 | 5.76 | 5.82 | 5.84 | 0.493 | 0.141 |
Model 2e | 5.92 | 6.02 | 6.14 | 6.12 | 0.380 | 0.102 |
Fasting plasma insulin (μU/ml) | ||||||
Model 1 | 5.79 | 5.62 | 6.31 | 6.07 | 0.513 | 0.304 |
Model 2 | 5.95 | 5.80 | 6.57 | 6.24 | 0.443 | 0.308 |
HOMA-IR | ||||||
Model 1 | 1.45 | 1.46 | 1.61 | 1.59 | 0.453 | 0.158 |
Model 2 | 1.53 | 1.54 | 1.72 | 1.67 | 0.338 | 0.137 |
Fructosamine (μmol/l) | ||||||
Model 1 | 258 | 253 | 257 | 256 | 0.647 | 0.952 |
Model 2 | 267 | 261 | 266 | 264 | 0.428 | 0.815 |